Aligos Therapeutics, Inc. (ALGS)
2.15
-0.42
(-16.34%)
USD |
NASDAQ |
Nov 11, 16:00
2.09
-0.06
(-2.79%)
After-Hours: 19:46
Aligos Therapeutics Price to Book Value : 1.188 for Nov. 11, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 10, 2026 | 1.420 |
| November 09, 2026 | 2.183 |
| November 06, 2026 | 2.249 |
| November 05, 2026 | 2.492 |
| November 04, 2026 | 2.774 |
| November 03, 2026 | 2.625 |
| November 02, 2026 | 2.542 |
| October 30, 2026 | 2.653 |
| October 29, 2026 | 2.780 |
| October 28, 2026 | 2.857 |
| October 27, 2026 | 2.620 |
| October 26, 2026 | 2.570 |
| October 23, 2026 | 2.642 |
| October 22, 2026 | 2.664 |
| October 21, 2026 | 2.741 |
| October 20, 2026 | 2.780 |
| October 19, 2026 | 2.675 |
| October 16, 2026 | 2.686 |
| October 15, 2026 | 2.979 |
| October 14, 2026 | 2.890 |
| October 13, 2026 | 3.045 |
| October 12, 2026 | 3.056 |
| October 09, 2026 | 2.951 |
| October 08, 2026 | 2.935 |
| October 07, 2026 | 2.940 |
| Date | Value |
|---|---|
| October 06, 2026 | 2.973 |
| October 05, 2026 | 2.984 |
| October 02, 2026 | 3.062 |
| October 01, 2026 | 3.040 |
| September 30, 2026 | 3.112 |
| September 29, 2026 | 1.099 |
| September 28, 2026 | 1.084 |
| September 25, 2026 | 1.078 |
| September 24, 2026 | 1.086 |
| September 23, 2026 | 1.088 |
| September 22, 2026 | 1.111 |
| September 21, 2026 | 1.074 |
| September 18, 2026 | 1.025 |
| September 17, 2026 | 1.011 |
| September 16, 2026 | 0.9878 |
| September 15, 2026 | 0.9761 |
| September 14, 2026 | 0.9859 |
| September 11, 2026 | 1.021 |
| September 10, 2026 | 1.043 |
| September 09, 2026 | 1.076 |
| September 08, 2026 | 1.127 |
| September 04, 2026 | 1.215 |
| September 03, 2026 | 1.217 |
| September 02, 2026 | 1.215 |
| September 01, 2026 | 1.191 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.64 |
| Anika Therapeutics, Inc. | 1.354 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 0.7797 |
Price to Book Value Related Metrics
| PS Ratio | 0.6658 |
| Price | 2.15 |
| Earnings Yield | -296.0% |
| Market Cap | 13.43M |